High frequency of BTG1 deletions in patients with BCR-ABL1–positive acute leukemia

Rouault, 1993, Sequence analysis reveals that the BTG1 anti-proliferative gene is conserved throughout evolution in its coding and 3′ non-coding regions, Gene, 129, 303, 10.1016/0378-1119(93)90284-A Berthet, 2002, Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects, Genes Cells, 7, 29, 10.1046/j.1356-9597.2001.00497.x Winkler, 2010, The mammalian anti-proliferative BTG/Tob protein family, J Cell Physiol, 222, 66, 10.1002/jcp.21919 Prévôt, 2000, The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation, J Biol Chem, 275, 147, 10.1074/jbc.275.1.147 Busson, 2005, Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation, Oncogene, 24, 1698, 10.1038/sj.onc.1208373 Lin, 1996, The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase, J Biol Chem, 271, 15034, 10.1074/jbc.271.25.15034 van Galen, 2010, BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia, Blood, 115, 4810, 10.1182/blood-2009-05-223081 Kuiper, 2007, High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression, Leukemia, 21, 1258, 10.1038/sj.leu.2404691 Waanders, 2012, The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution, PLoS Genet, 8, e1002533, 10.1371/journal.pgen.1002533 Tsuzuki, 2007, Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization, Cancer Sci, 98, 698, 10.1111/j.1349-7006.2007.00443.x Ferrari, 2013, Adult B-cell precursor acute lymphoblastic leukemia (BC-ALL) negative for recurrent fusion genes are characterized by a high complex genetic heterogeneity influencing prognosis, Blood, 122, 2622, 10.1182/blood.V122.21.2622.2622 Matutes, 2011, Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification, Blood, 117, 3163, 10.1182/blood-2010-10-314682 Armstrong, 2005, Molecular genetics of acute lymphoblastic leukemia, J Clin Oncol, 23, 6306, 10.1200/JCO.2005.05.047 Mullighan, 2007, Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature, 446, 758, 10.1038/nature05690 Zhang, 2011, Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group, Blood, 118, 3080, 10.1182/blood-2011-03-341412 Tijchon, 2013, B-lineage transcription factors and cooperating gene lesions required for leukemia development, Leukemia, 27, 541, 10.1038/leu.2012.293 Clark, 1988, Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL), Science, 239, 775, 10.1126/science.3422516 Shtivelman, 1986, Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene, Cell, 47, 277, 10.1016/0092-8674(86)90450-2